Ambu AS ADR AMBBY
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $13.20
- Day Range
- $13.60–13.60
- 52-Week Range
- $8.55–14.18
- Bid/Ask
- $5.89 / $18.63
- Shares Outstanding
- 260.65M
- Market Cap
- $3.60B
- Volume/Avg
- 1,000 / 631
Key Statistics
- Price/Earnings (Normalized)
- 32.59
- Price/Sales
- 3.58
- Dividend Yield (Trailing)
- 0.47%
- Dividend Yield (Forward)
- 0.47%
- Dividend Payment Schedule
- Dec
- Total Yield
- 2.46%
Company Profile
Ambu AS provides medical technology solutions. The company's business consists of research and development of new solutions, which are then manufactured, marketed, and sold. It operates in two verticals: Endoscopy Solutions and Anesthesia & Patient Monitoring, with the majority of revenue being generated from the Endoscopy Solutions business. Geographical segments include North America, Europe, and the Rest of the World.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Mid Growth
- Total Number of Employees
- 5,498
- Website
- https://www.ambu.com
Valuation
Metric | AMBBY |
|---|---|
Price/Earnings (Normalized) | 32.59 |
Price/Book Value | 3.74 |
Price/Sales | 3.58 |
Price/Cash Flow | 19.16 |
Price/Earnings
AMBBY
Financial Strength
Metric | AMBBY |
|---|---|
Quick Ratio | 1.21 |
Current Ratio | 2.35 |
Interest Coverage | 33.72 |
Quick Ratio
AMBBY
Profitability
Metric | AMBBY |
|---|---|
Return on Assets (Normalized) | 8.75% |
Return on Equity (Normalized) | 11.12% |
Return on Invested Capital (Normalized) | 10.21% |
Return on Assets
AMBBY
Medical Devices Industry Comparables
1-Day Chart | Name | Price | Morningstar Rating for Stocks | Capital Allocation | Economic Moat | Market Cap |
|---|---|---|---|---|---|---|
| Abbott Laboratories ABT | LOCK|rM^zs# | LOCK|X&#^ | $197B | |||
| Medtronic PLC MDT | LOCK|P!<sYK | LOCK|H!Z^ | $134B | |||
| Stryker Corp SYK | LOCK|l#T<Xmp | LOCK|#N | $128B | |||
| Boston Scientific Corp BSX | LOCK|px<J#K | LOCK|kd%>@ | $65B | |||
| Edwards Lifesciences Corp EW | LOCK|<lM@^zj$ | LOCK|ndd# | $58B | |||
| GE HealthCare Technologies Inc Common Stock GEHC | LOCK|>>v!xd | LOCK|sB | $38B | |||
| DexCom Inc DXCM | LOCK|w$Q&#>&< | LOCK|ymc&^ | $31B | |||
| Koninklijke Philips NV ADR PHG | LOCK|#M | LOCK|lb! | $30B | |||
| Steris PLC STE | LOCK|>FD>&h# | LOCK|Bnhp | $25B | |||
| Zimmer Biomet Holdings Inc ZBH | LOCK|j<vy%>$z | LOCK|l&D | $20B |
United States